We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+2.31%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$5.5B
AUM Growth
+$58M
Cap. Flow
-$11.2M
Cap. Flow %
-0.2%
Top 10 Hldgs %
36.95%
Holding
821
New
51
Increased
87
Reduced
185
Closed
82

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$25.4M
2
AMZN icon
Amazon
AMZN
+$17.1M
3
ROP icon
Roper Technologies
ROP
+$14.2M
4
TEL icon
TE Connectivity
TEL
+$12.1M
5
MSFT icon
Microsoft
MSFT
+$9.04M

Top Sells

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$11.6M
2
TJX icon
TJX Companies
TJX
+$10.8M
3
JNJ icon
Johnson & Johnson
JNJ
+$8.91M
4
PG icon
Procter & Gamble
PG
+$8.9M
5
META icon
Meta Platforms (Facebook)
META
+$8.24M

Sector Composition

Rank Sector Weight
1 Technology 27.8%
2 Healthcare 17.78%
3 Financials 10.19%
4 Consumer Staples 9.56%
5 Consumer Discretionary 9.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BKI
801
DELISTED
Black Knight, Inc. Common Stock
BKI
– –
-72
Closed -$3K
RDUS
802
DELISTED
Radius Health, Inc.
RDUS
$0 ﹤0.01%
10
– –
COHR
803
DELISTED
Coherent Inc
COHR
– –
-4
Closed -$1K
ALXN
804
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-14
Closed -$2K
NE
805
DELISTED
Noble Corporation
NE
– –
-100
Closed –
PTLA
806
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$0 ﹤0.01%
10
– –
ZAYO
807
DELISTED
Zayo Group Holdings, Inc.
ZAYO
– –
-800
Closed -$29K
WP
808
DELISTED
Worldpay, Inc.
WP
– –
-23
Closed -$2K
LEXEA
809
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
$0 ﹤0.01%
21
– –
DNB
810
DELISTED
Dun & Bradstreet
DNB
– –
-199
Closed -$24K
SCG
811
DELISTED
Scana
SCG
– –
-9
Closed –
EVHC
812
DELISTED
Envision Healthcare Holdings Inc
EVHC
– –
-9
Closed –
DYN
813
DELISTED
Dynegy, Inc.
DYN
– –
-1,200
Closed -$14K
LVNTA
814
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
– –
-31
Closed -$2K
BIVV
815
DELISTED
Bioverativ Inc. Common Stock
BIVV
– –
-4,241
Closed -$229K
SNI
816
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
– –
-12
Closed -$1K
DISH
817
DELISTED
DISH Network Corp.
DISH
– –
-16
Closed –
UFS
818
DELISTED
DOMTAR CORPORATION (New)
UFS
– –
-28
Closed -$1K
GRA
819
DELISTED
W.R. Grace & Co.
GRA
$0 ﹤0.01%
11
– –
WLH
820
DELISTED
WILLIAM LYON HOMES
WLH
– –
-46
Closed -$1K
DST
821
DELISTED
DST Systems Inc.
DST
– –
-14
Closed –
29 30 31 32
33

Similar funds

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
URS
Utah Retirement Systems Salt Lake City, Utah $9.78B AUM 28.72% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's Q1 2018 Portfolio in Review

As of Q1 2018, Loring Wolcott & Coolidge Fiduciary Advisors held 821 positions worth $5.5B, up 1.1% from $5.45B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q1 2018 filing shows 51 new, 87 increased, 185 reduced and 82 closed positions. Its largest new stake was Diamondback Energy: 3,285 shares worth $416K. The largest sale was Novo Nordisk, an estimated $11.6M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q1 2018 buy was Diamondback Energy: 3,285 shares worth $416K.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Becton Dickinson in Q1 2018, an estimated $25.4M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q1 2018 reduction was Novo Nordisk, cutting an estimated $11.6M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $229K.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 37% of its $5.5B portfolio in Q1 2018.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 51 new positions and closed 82 in Q1 2018.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value rose 1.1% quarter-over-quarter to $5.5B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q1 2018, filed 20 Apr 2018.